These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Clinical year in review I: interstitial lung disease, occupational and environmental lung disease, education of residents and fellows, and pediatrics. Schmidt SL; Flaherty KR Proc Am Thorac Soc; 2011 Sep; 8(5):389-97. PubMed ID: 21926388 [No Abstract] [Full Text] [Related]
15. Selected clinical highlights from the 2012 ERS congress in Vienna. Marvisi M; Herth FJ; Ley S; Poletti V; Chavannes NH; Spruit MA; Clini E; Cottin V Eur Respir J; 2013 May; 41(5):1219-27. PubMed ID: 23222869 [TBL] [Abstract][Full Text] [Related]
16. Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care. Frank AL; Kreuter M; Schwarzkopf L Respir Med; 2019 Jun; 152():25-31. PubMed ID: 31128606 [TBL] [Abstract][Full Text] [Related]
17. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients. Feng H; Zhao Y; Li Z; Kang J Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705 [TBL] [Abstract][Full Text] [Related]